Screening children for sickle cell vasculopathy: guidelines for transcranial Doppler evaluation

Dorothy Bulas1

  • 1Department of Diagnostic Imaging and Radiology, Children's National Medical Center, George Washington University School of Medicine, 111 Michigan Ave. NW, Washington, DC 20010, USA. dbulas@cnmc.org

Pediatric Radiology
|February 11, 2005
PubMed

Insights

Identifying children at high risk for cerebral infarction in sickle cell disease is possible with Transcranial Doppler (TCD) screening. This noninvasive method helps prevent strokes in pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Hematology
  • Medical Imaging

Background:

  • Cerebral infarction poses significant risks for children with sickle cell disease.
  • Effective primary stroke prevention strategies are needed for this vulnerable population.

Purpose of the Study:

  • To evaluate Transcranial Doppler (TCD) as a tool for identifying children with sickle cell disease at high risk of cerebral infarction.
  • To review the protocol and findings of the Stroke Prevention Trial in Sickle Cell Anemia (STOP).

Main Methods:

  • Discussion of imaging and non-imaging Transcranial Doppler (TCD) techniques.
  • Review of the Stroke Prevention Trial in Sickle Cell Anemia (STOP) protocol, including data acquisition and interpretation.

Main Results:

  • Transcranial Doppler (TCD) is a reliable, noninvasive, and cost-effective method for identifying high-risk pediatric patients.
  • The STOP trial protocol provides a framework for stroke risk assessment and intervention.

Conclusions:

  • Implementing Transcranial Doppler (TCD) screening for sickle cell patients can significantly reduce first stroke rates.
  • Early identification and intervention are crucial for preventing cerebral infarction in children with sickle cell disease.